Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells

Endocrinology

Volumn 144, Issue 2, 2003, Pages 693-700

  Perez Castro, Carolina ^a   Giacomini, Damiana ^a   Carbia Nagashima, Alberto ^a   Onofri, Chiara ^b   Graciarena, Mariana ^a   Kobayashi, Ken ^a   Páez Pereda, Marcelo ^b   Renner, Ulrich ^b   Stalla, Günter K ^b   Arzt, Eduardo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN GH3; CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH HORMONE RELEASE; HORMONE RELEASE; HYPOPHYSIS CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; ANTIGENS, CD; CELL DIVISION; CYTOKINE RECEPTOR GP130; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PITUITARY NEOPLASMS; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037318548     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220891     Document Type: Article

References (46)

1. Hibi M, Nakajima K, Hirano T 1996 IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74:1-12
2. Kishimoto T, Taga T, Akira S 1994 Cytokine signal transduction. Cell 76:253-262
3. Kishimoto T, Akira S, Narazaki M, Taga T 1995 Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254
4. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L 1998 Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 334:297-314
5. Ohmichi M, Hirota K, Koike K, Kurachi H, Ohtsuka S, Matsuzaki N, Yamaguchi M, Miyake A, Tanizawa O 1992 Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinology 55:199-203
6. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor. Novel intra-pituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 95:1288-1298
7. Auernhammer CJ, Melmed S 1999 Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology 140:1559-1566
8. Perez Castro C, Carbia Nagashima A, Páez-Pereda M, Goldberg V, Chervin A, Largen P, Renner U, Stalla GK, Arzt E 2000 The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines. Endocrinology 141:1746-1753
9. Arzt E 2001 Gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 108:1729-1733
10. Busquet C, Zatelli MC, Melmed S 2000 Direct regulation of pituitary pro-opiomelanocortin by STAT3 provides a novel mechanism for immunoneuroendocrine interfacing. J Clin Invest 106:1417-1425
11. Auernhammer CJ, Melmed S 2001 The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest 108:1735-1740
12. Spangelo BL, Judd AM, Isakson PC, MacLeod RM 1989 Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 127:575-577
13. Spangelo BL, Gorospe WC 1995 Role of the cytokines in the neuroendocrine-immune system axis. Front Neuroendocrinol 16:1-12
14. Ray D, Melmed S 1997 Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228
15. Arzt E, Páez-Pereda M, Perez Castro C, Pagotto U, Rennet U, Stalla GK 1999 Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71-95
16. Auernhammer CJ, Melmed S 2000 Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 21:313-345
17. Páez-Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervín A, Berner S, Molina H, Stalla GK, Arzt E 2000 Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocr Diabetes 108:202-207
18. Perez Castro C, Nagashima AC, Páez-Pereda M, Goldberg V, Chervín A, Carrizo G, Molina H, Renner U, Stalla Gk, Arzt E 2001 Effects of the gp130 cytokines CNTF and IL-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of PRL and GH secretion in normal rat anterior pituitary aggregate cultures. J Endocrinol 169:539-547
19. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK 1993 Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6. Endocrinology 132:459-467
20. Renner U, Gloddek J, Arzt E, Inoue K, Stalla GK 1997 Interleukin-6 is an autocrine growth factor for TtT/GF mouse pituitary cells. Exp Clin Endocrinol Diabetes 105:345-352
21. Sawada T, Koike K, Kanda Y, Ikegami H, Jikihara T, Maeda T, Osako Y, Hirota K, Miyake A 1995 Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro. J Endocrinol Invest 18:83-90
22. Koyama C, Matsumoto H, Sakai T, Wakabayashi K, Ito A, Couch EF, Inoue K 1995 Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice. Endocr Pathol 6:67-75
23. Páez-Pereda M, Goldberg V, Chervín A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla GK, Arzt E 1996 Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol 124:33-42
24. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T 1992 Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 148:4066-4071
25. Wen Z, Zhong Z, Darnell JJ 1995 Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250
26. Williams C, Baer M, Dillner A, Johnson P 1995 CRP2 (c/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J 14:3170-3183
27. Farrow KN, Manning N, Schaufele F, Gutierrez-Hartmann A 1996 The c-Jun γ-domain inhibits neuroendocrine promoter activity in a DNA sequence and pituitary-specific manner. J Biol Chem 271:17139-17146
28. Tanuma N, Nakamura K, Shima H, Kikuchi K 2000 Protein-tyrosine phosphatase PTPεC inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. J Biol Chem 275:28216-28221
29. Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK 1992 Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest 90:1944-1951
30. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ 1997 A family of cytokine-inducible inhibitors of signaling. Nature 387:917-921
31. Arzt E, Sauer J, Pollmacher T, Labeur M, Holsboer F, Reul JMHM, Stalla GK 1994 Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 134:672-677
32. Páez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grubler Y, Missale C, Arzt E, Stalla G 2001 Retinoic acid prevents experimental Cushing syndrome. J Clin Invest 108:1123-1131
33. Asa SL, Ezzat S 1998 The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827
34. Melmed S 2001 Acromegaly and cancer: Not a problem? J Clin Endocrinol Metab 86:2929-2934
35. Pei L, Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441
36. Horiguchi A, Oya M, Marumo K, Murai M 2002 STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P. Kidney Int 61:926-938
37. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC 2002 Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 290:249-255
38. Campbell CL, Jiang Z, Savarese DM, Savarese TM 2001 Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 158:25-32
39. Burger R, Guenther A, Bakker F, Schmalzing M, Bernand S, Baum W, Duerr B, Hocke GM, Steininger H, Gebhart E, Gramatzki M 2001 Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma. Hematol J 2:42-53
40. Gloddek J, Pagotto U, Páez-Pereda M, Arzt E, Stalla GK, Rennet U 1999 Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 160:483-490
41. Leung CKH, Shiu PC 1981 Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res 41:546-551
42. Yano T, Uozumi T, Kawamoto K, Mukada K, Onda J, Ito A, Fujimoto N 1991 Photodynamic therapy for rat pituitary tumor in vitro and in vivo using pheophorbide-A and white light. Lasers Surg Med 11:174-182
43. Davalli AM, Galbiati F, Bertuzzi F, Polastri L, Pontiroli AE, Perego L, Freschi M, Pozza G, Folli F, Meoni C 2000 Insulin-secreting pituitary GH3 cells: a potential β-cell surrogate for diabetes cell therapy. Cell Transplant 9:841-851
44. Nakashima K, Taga T 1998 Gp130 and IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities. Semin Hematol 35:210-221
45. Taga T, Narazaki M, Yasukawa K, Saito T, Daisuke M, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, Kishimoto T 1992 Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 89:10998-11001
46. Tone E, Kunisawa K, Kumanogoh A, Negoro S, Funamoto M, Osugi T, Kishimoto T, Yamauchi-Takihara K 2000 Gp130-dependent signaling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Cytokine 12:1512-1518